Smith Group Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,372
| Closed | -$63K | – | 382 |
|
|
2020
Q1 | $63K | Hold |
1,372
| – | – | ﹤0.01% | 235 |
|
|
2019
Q4 | $82K | Hold |
1,372
| – | – | ﹤0.01% | 248 |
|
|
2019
Q3 | $78K | Hold |
1,372
| – | – | ﹤0.01% | 250 |
|
|
2019
Q2 | $76K | Hold |
1,372
| – | – | ﹤0.01% | 254 |
|
|
2019
Q1 | $69K | Sell |
1,372
-80
| -6% | -$4.02K | ﹤0.01% | 282 |
|
|
2018
Q4 | $59K | Hold |
1,452
| – | – | ﹤0.01% | 294 |
|
|
2018
Q3 | $101K | Hold |
1,452
| – | – | ﹤0.01% | 274 |
|
|
2018
Q2 | $110K | Sell |
1,452
-1,930
| -57% | -$146K | ﹤0.01% | 279 |
|
|
2018
Q1 | $178K | Sell |
3,382
-118
| -3% | -$6.21K | 0.01% | 262 |
|
|
2017
Q4 | $187K | Buy |
+3,500
| New | +$187K | 0.01% | 260 |
|